Hyoung Jin Kang, MD, PhD

Articles

Dr. Kang on Aprepitant for Preventing CINV in Children

July 03, 2014

Hyoung Jin Kang, MD, PhD, associate professor, Department of Pediatrics, Seoul National University, South Korea, discusses a phase III trial of aprepitant for chemotherapy-induced nausea and vomiting (CINV) in children.